Skip to content

Deep Anterior Lamellar Keratoplasty Using Dehydrated Versus Standard Organ Culture Stored Donor Corneas

Deep Anterior Lamellar Keratoplasty Using Dehydrated Versus Standard Organ Culture Stored Donor Corneas: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04430244
Enrollment
60
Registered
2020-06-12
Start date
2020-06-17
Completion date
2023-05-31
Last updated
2020-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratoconus

Brief summary

The objective of this study is to assess the outcomes between deep anterior lamellar keratoplasty using dehydrated versus standard organ culture stored donor corneas.

Detailed description

Keratoconus is a common corneal disease characterized by progressive thinning and steepening resulting in significant visual impairment. With improved instrumentation and corneal imaging technology, deep anterior keratoplasty has been recognized as the preferred primary operative technique for cases of keratoconus requiring corneal transplantation. Since corneas preserved through organ culture remain viable only for up to 4 weeks, techniques that can extend storage of corneas have been explored. The objective of this study is to assess the outcomes between deep anterior lamellar keratoplasty using dehydrated versus standard organ culture stored donor corneas.

Interventions

Deep anterior lamellar keratoplasty using dehydrated corneas

Sponsors

Istituto Internazionale di Ricerca e Formazione in Oftalmologia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Keratoconus * Surgical candidates for deep anterior lamellar keratoplasty

Exclusion criteria

* Ocular comorbidities other than cataract (ie. visual significant optic nerve or macular disease) * Previous corneal transplantations or other ocular surgeries except uncomplicated cataract surgery * Inability to comply with study protocol or participate in follow-up visits

Design outcomes

Primary

MeasureTime frameDescription
Change in best spectacle-corrected visual acuityPreoperatively; and 6 and 12 months postoperativelyMeasured as the difference in best spectacle-corrected visual acuity preoperative, 6 and 12 months postoperatively using ETDRS chart

Secondary

MeasureTime frameDescription
Change in astigmatismPreoperatively; and 6 and 12 months postoperativelyTopographic astigmatism (Diopters) is measured using anterior segment optical coherence tomography (CASIA)
Change in Thinnest-point pachymetryPreoperatively; and 6 and 12 months postoperativelyThinnest-point pachymetry values (um) are measured using anterior segment optical coherence tomography (CASIA)
Change in endothelial cell densityPreoperatively; and 6 and 12 months postoperativelyMeasured using noncontact specular microscopy
Incidence of graft failure6 and 12 months postoperativelyClinically assessed during postoperative examinations
Corneal donor loss due to preparationIntraoperativeBased on intraoperative assessment of corneas unusable for corneal transplantation
Incidence of graft rejection6 and 12 months postoperativelyClinically assessed during postoperative examinations

Other

MeasureTime frameDescription
Refraction6 and 12 months postoperativelyMeasured by manifest refraction
Adverse Events/Complicationup to 12 months postoperativelyComparison of total rates of adverse events/complications assessed clinically

Countries

Italy

Contacts

Primary ContactMassimo Busin, MD
mbusin@yahoo.com+393473448343
Backup ContactAngeli Christy Yu, MD
angeliyu@gmail.com+393663903896

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026